Cargando…
Correction to: Nitrogen-based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360457/ https://www.ncbi.nlm.nih.gov/pubmed/35713532 http://dx.doi.org/10.1093/jnci/djac118 |
Ejemplares similares
-
Nitrogen-based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50
Years and Older
por: Tuesley, Karen M, et al.
Publicado: (2022) -
Correction to: Bisphosphonates and mortality: confounding in observational studies
por: Bergman, J., et al.
Publicado: (2021) -
Correction to: The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
por: Zheng, Zaoqian, et al.
Publicado: (2020) -
Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2023) -
Bisphosphonate Treatment Beyond 5 Years and Hip Fracture Risk in Older Women
por: Izano, Monika A., et al.
Publicado: (2020)